|
rdfs:label
|
"Midodrin"@de
"Midodrin"@sh
"Midodrin"@sr-el
"Midodrin"@tr
"Midodrina"@es
"Midodrina"@pt
"Midodrine"@vi
"midodriini"@fi
"midodrin"@cy
"midodrin"@nn
"midodrin"@sl
"midodrina"@ca
"midodrine"@en
"midodrine"@fr
"midodryna"@pl
"Мидодрин"@sr-ec
"Мидодрин"@ru
"мидодрин"@sr
"ميدودرين"@ar
"میدودرین"@fa
"ମିଡୋଡ୍ରାଇନ"@or
"మిడోడ్రైన్"@te
"ミドドリン"@ja
"甲氧安福林"@zh
"미도드린"@ko
|
|
skos:altLabel
|
"(+-)-2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide"@cy
"(+-)-2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide"@en
"1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol"@cy
"1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol"@en
"133163-28-7"@fr
"2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide"@cy
"2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide"@en
"A-4020 Linz"@cy
"A-4020 Linz"@en
"ATC kod C01CA17"@sr
"ATCvet kod QC01CA17"@sr
"Amatin"@sr
"Amatine"@sr
"C12H18N2O4"@fr
"C12H18N2O4"@sr
"DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid"@cy
"DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid"@en
"Gutron"@sr
"Gutrone"@sr
"Midodrin"@en
"Midodrina"@en
"Midodrine"@en
"Midodrine"@sr
"Midodrinum"@en
"Proamatin"@sr
"Proamatine"@sr
"Proamatine®"@cy
"Proamatine®"@en
"ST-1085"@cy
"ST-1085"@en
|
|
schema:description
|
"cheemesch Verbindung"@lb
"chemical compound"@en-ca
"chemical compound"@en-gb
"chemická sloučenina"@cs
"chemická zlúčenina"@sk
"chemiese verbinding"@af
"chemische Verbindung"@de-ch
"chemische verbinding"@nl
"component quimic"@oc
"compositum chemicum"@la
"compost químic"@ca
"composto chimico"@it
"composto químico"@gl
"composto químico"@pt
"composto químico"@pt-br
"composé chimique"@fr
"compuesto quimico"@an
"compuesto químico"@es
"compuestu químicu"@ast
"compus chimic"@ro
"kemia kombinaĵo"@eo
"kemiallinen yhdiste"@fi
"kemisk forbindelse"@da
"kjemisk forbindelse"@nb
"kjemisk sambinding"@nn
"komponim kimik"@sq
"konposatu kimiko"@eu
"organische Verbindung, Arzneistoff"@de
"peripheral alpha-1 agonist used for the treatment of dysautonomia and orthostatic hypotension"@en
"senyawa kimia"@id
"związek chemiczny"@pl
"ķīmisks savienojums"@lv
"хемиско соединение"@mk
"хімічна сполука"@uk
"քիմիական միացություն"@hy
"תרכובת"@he
"مركب كيميائي"@ar
"کیٖمیٲیی مُرَکَب"@ks
"রাসায়নিক যৌগ"@bn
"ଠିଆ ହେଲେ ନିମ୍ନ ରକ୍ତଚାପ ହେଉଥିଲେ ଏହି ଔସଧ ଦିଆଯାଏ ।"@or
"ఔషధం"@te
"രാസസംയുക്തം"@ml
"혈압을 높이는 약물"@ko
|
|
schema:dateModified
|
"2026-10-26T07:55:22+00:00"^^xsd:dateTime
|
|
schema:version
|
2561002684
|
|
wikibase:identifiers
|
40
|
|
wikibase:sitelinks
|
19
|
|
wikibase:statements
|
58
|
|
p:P10245
|
wd:statement/Q415051-e485b583-458d-b53e-d007-c22b3f5c62c8
|
|
p:P10283
|
wd:statement/Q415051-97080648-C86D-413D-AD8C-A3C8B6D18DB0
|
|
p:P11089
|
wd:statement/Q415051-27DF8231-C9DF-4279-A334-F923893D8A32
|
|
p:P11143
|
wd:statement/Q415051-829BD97B-813A-46FF-AC78-7A6C2775BB7D
|
|
p:P11198
|
wd:statement/Q415051-BB323B19-992B-44B8-B36C-50FE8FC71E96
|
|
p:P11199
|
wd:statement/Q415051-7AE5B3D4-1031-4FA9-A0F1-5C3178F30C00
|
|
p:P117
|
wd:statement/Q415051-05c23089-4995-902c-93c8-29e1d40da038
|
|
p:P1579
|
wd:statement/Q415051-37D14E57-D377-4A24-8501-1E30F05FFA96
|
|
p:P2057
|
wd:statement/Q415051-68F6842A-075C-4D66-8EBF-43D89C881888
|
|
p:P2062
|
wd:statement/Q415051-E8301C35-EC77-4B02-8CB9-63B72EACDD8A
|
|
p:P2067
|
wd:statement/Q415051-5F0CFADD-A0CB-413A-9022-4F835DA6EDDF
|
|
p:P2115
|
wd:statement/Q415051-DF858644-E9B4-439B-BFDE-75A5F89C65A2
|
|
p:P2175
|
wd:statement/Q415051-12CBFF06-2428-44D9-B607-D929E20B9800
|
|
wd:statement/Q415051-FE2E748C-5A91-45B6-8E94-4840708F1A5F
|
|
p:P2275
|
wd:statement/Q415051-93709D8D-FB8E-486D-995E-ED7ECC21ED66
|
|
p:P231
|
wd:statement/Q415051-C04CD8C3-FB17-4740-8593-53F7D29AD405
|
|
p:P232
|
wd:statement/Q415051-73290AC6-AE82-4A95-9952-C5DD3AB31D0E
|
|
wd:statement/Q415051-C9D9EB68-C081-4A27-877C-20061F20A815
|
|
p:P233
|
wd:statement/Q415051-724FF56D-4B7B-4E6A-A9A6-F0B601EBBF97
|
|
p:P234
|
wd:statement/Q415051-C3EBFBE2-92E2-45D8-8E52-57BB4D05BE11
|
|
p:P235
|
wd:statement/Q415051-FFBE9CA8-CE58-4791-89F7-F43A798FEAE9
|
|
p:P2566
|
wd:statement/Q415051-3F844060-7F5C-475C-822E-E51CC14A2C54
|
|
wd:statement/Q415051-E70D8E34-85AA-4EEF-A057-D22AFE3914B3
|
|
p:P267
|
wd:statement/Q415051-D91172E5-6466-4B73-9B10-263D511BA829
|
|
p:P274
|
wd:statement/Q415051-2BB764B8-B666-41E0-9534-B61307E95624
|
|
p:P279
|
wd:statement/Q415051-5C50DCCE-A85E-4560-895E-692E7F5FE58C
|
|
p:P2868
|
wd:statement/Q415051-3DBC31ED-1995-4B0C-8DCD-23A807370A59
|
|
wd:statement/Q415051-4AF6DD55-6C5C-4898-A572-32CEE8895C84
|
|
wd:statement/Q415051-9A19E485-E305-4FD6-A75D-C417C639B7A8
|
|
wd:statement/Q415051-C4FD0D6B-4452-488D-89DF-F08A047F4C7B
|
|
p:P2877
|
wd:statement/Q415051-6F0246C5-90D6-4245-8445-66AECA26DFB7
|
|
wd:statement/Q415051-838282E3-B0AD-4516-B960-C582810A3408
|
|
p:P2892
|
wd:statement/Q415051-49A28D0C-DAED-413C-9E9F-A72467410AE8
|
|
p:P31
|
wd:statement/Q415051-533B3E3E-F040-4C7E-B81F-DEC6956F9A81
|
|
p:P3117
|
wd:statement/Q415051-BAD6E3A4-1A9E-4298-9615-D0A6B583ADB9
|
|
p:P3345
|
wd:statement/Q415051-7B41F67F-7A99-4F0A-8523-C42C58AB72DE
|
|
p:P3417
|
wd:statement/Q415051-FEDC56C4-BF7D-4A48-84E6-21A28EB87314
|
|
p:P366
|
wd:statement/Q415051-439C0336-7504-4226-923A-12D83A715445
|
|
p:P373
|
wd:statement/Q415051-d94fd6f4-359f-41f5-a33b-1d948c719ca8
|
|
p:P3780
|
wd:statement/Q415051-79C99290-1D96-4A14-9FB5-136E7E73A513
|
|
p:P4250
|
wd:statement/Q415051-ACB797FA-06DF-43C6-84B4-EEF76F9BC140
|
|
p:P486
|
wd:statement/Q415051-3657E327-75CD-4181-8243-69B7C509F609
|
|
p:P5076
|
wd:statement/Q415051-FD35834E-810A-4BFD-B95E-51B38295F42C
|
|
p:P592
|
wd:statement/Q415051-181A03C7-5926-4136-826E-C4C1F0B56AF8
|
|
p:P595
|
wd:statement/Q415051-D9CEA350-CA6B-485E-A1BC-CDED5FCB51E7
|
|
p:P6366
|
wd:statement/Q415051-6F32CC5B-7B7B-48B2-9678-30786BC64490
|
|
p:P646
|
wd:statement/Q415051-7051A51A-2440-44AF-8F57-FBB176A25458
|
|
p:P652
|
wd:statement/Q415051-0D8BD1F1-BFA3-43BD-AF83-004325E246C0
|
|
p:P661
|
wd:statement/Q415051-E7FB9EAC-953C-468F-8FD3-3E995720AD66
|
|
p:P662
|
wd:statement/Q415051-A4059E77-5136-43E8-B608-EB7774FF00EA
|
|
p:P665
|
wd:statement/Q415051-7F108C5B-0F90-4889-AFAA-54A366952912
|
|
wd:statement/Q415051-990C2EBC-3BDE-449A-BF30-D855A37BF444
|
|
p:P672
|
wd:statement/Q415051-006f5410-4b06-eb18-1e2a-9912c84d409d
|
|
wd:statement/Q415051-8e477a8a-4745-b0f0-9c89-ff43c325e05c
|
|
p:P683
|
wd:statement/Q415051-8AB095D2-53C6-4362-A871-4881D0BD3B42
|
|
p:P715
|
wd:statement/Q415051-DF63C878-E66B-4EFC-83B8-AD8DFBDCB1B9
|
|
p:P769
|
wd:statement/Q415051-502E2295-5615-4CE2-ADC3-353BA003A414
|
|
p:P8494
|
wd:statement/Q415051-5DD4C1D8-ACA9-43E0-8E24-152F6CF4BCF7
|
|
p:direct-normalized/P2115
|
<http://purl.bioontology.org/ontology/NDFRT/N0000022049>
|
|
p:direct-normalized/P486
|
<http://id.nlm.nih.gov/mesh/D008879>
|
|
p:direct-normalized/P592
|
<http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL1201212>
|
|
p:direct-normalized/P6366
|
<https://makg.org/entity/2780081974>
|
|
p:direct-normalized/P661
|
<http://rdf.chemspider.com/4050>
|
|
p:direct-normalized/P662
|
<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4195>
|
|
p:direct-normalized/P665
|
<http://www.kegg.jp/entry/C07890>
|
|
<http://www.kegg.jp/entry/D08220>
|
|
p:direct-normalized/P672
|
<http://id.nlm.nih.gov/mesh/D02.033.100.291.480>
|
|
<http://id.nlm.nih.gov/mesh/D02.092.063.291.480>
|
|
p:direct-normalized/P683
|
<http://purl.obolibrary.org/obo/CHEBI_6933>
|
|
wdt:P10245
|
"a616030"
|
|
wdt:P10283
|
"C2780081974"
|
|
wdt:P11089
|
"229703"
|
|
wdt:P11143
|
"Midodrine"
|
|
wdt:P11198
|
"1803"
|
|
wdt:P11199
|
"PD010170"
|
|
wdt:P117
|
<http://commons.wikimedia.org/wiki/Special:FilePath/Midodrine.svg>
|
|
wdt:P1579
|
"2384653"
|
|
wdt:P2057
|
"HMDB0014356"
|
|
wdt:P2062
|
"7854"
|
|
wdt:P2067
|
254.126657^^xsd:decimal
|
|
wdt:P2115
|
"N0000022049"
|
|
wdt:P2175
|
urinary incontinence
|
|
orthostatic hypotension
|
|
wdt:P2275
|
"midodrine"@en
|
|
wdt:P231
|
"42794-76-3"
|
|
wdt:P232
|
"255-945-3"
|
|
"622-590-4"
|
|
wdt:P233
|
"COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O"
|
|
wdt:P234
|
"InChI=1S/C12H18N2O4/c1-17-8-3-4-11(18-2)9(5-8)10(15)7-14-12(16)6-13/h3-5,10,15H,6-7,13H2,1-2H3,(H,14,16)"
|
|
wdt:P235
|
"PTKSEFOSCHHMPD-UHFFFAOYSA-N"
|
|
wdt:P2566
|
"100.050.842"
|
|
"100.151.349"
|
|
wdt:P267
|
"C01CA17"
|
|
wdt:P274
|
"C₁₂H₁₈N₂O₄"
|
|
wdt:P279
|
chemical compound
|
|
wdt:P2868
|
vasoconstrictor agents
|
|
alpha-adrenergic agonist
|
|
Adrenergic alpha-1 Receptor Agonists
|
|
sympathomimetic drug
|
|
wdt:P2877
|
"131436"
|
|
"20996761"
|
|
wdt:P2892
|
"C0026078"
|
|
wdt:P31
|
type of chemical entity
|
|
wdt:P3117
|
"DTXSID0023321"
|
|
wdt:P3345
|
"6963"
|
|
wdt:P3417
|
"Midodrine"
|
|
wdt:P366
|
medication
|
|
wdt:P373
|
"Midodrine"
|
|
wdt:P3780
|
Proamatine
|
|
wdt:P4250
|
30.0^^xsd:decimal
|
|
wdt:P486
|
"D008879"
|
|
wdt:P5076
|
"RD-13-02230"
|
|
wdt:P592
|
"CHEMBL1201212"
|
|
wdt:P595
|
"7240"
|
|
wdt:P6366
|
"2780081974"
|
|
wdt:P646
|
"/m/071kv2"
|
|
wdt:P652
|
"6YE7PBM15H"
|
|
wdt:P661
|
"4050"
|
|
wdt:P662
|
"4195"
|
|
wdt:P665
|
"C07890"
|
|
"D08220"
|
|
wdt:P672
|
"D02.033.100.291.480"
|
|
"D02.092.063.291.480"
|
|
wdt:P683
|
"6933"
|
|
wdt:P715
|
"DB00211"
|
|
wdt:P769
|
phenelzine
|
|
wdt:P8494
|
"DTXCID903321"
|